A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema

被引:0
作者
Fernando, I. [1 ]
Scott, G. [1 ]
机构
[1] NHS Lothian, Chalmers Sexual Hlth Ctr, Edinburgh, Midlothian, Scotland
关键词
Multicentric Castleman's disease; human herpes virus-8; HHV-8; HIV; AIDS; HAART (highly-active anti-retroviral therapy); immune restoration inflammatory syndrome; acquired angioedema; RECONSTITUTION INFLAMMATORY SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; DEFICIENCY;
D O I
10.1177/0956462413516941
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multicentric Castleman's disease (MCD), a polyclonal lymphoproliferative disorder of unknown aetiology, is a well-recognised complication of HIV disease. We present a case of MCD in an HIV-positive patient that is unusual on two counts: our patient's MCD first presented in the context of an immune restoration inflammatory syndrome ( IRIS), following the initiation of highly active antiretroviral therapy ( HAART). In addition, her MCD was associated with the unusual complication of acquired angioedema (AAE), which resolved following treatment of the MCD. While AAE is frequently found to have an underlying diagnosis of a lymphoproliferative disease, this is the first reported case linking AAE to MCD.
引用
收藏
页码:523 / 525
页数:3
相关论文
共 12 条
[1]   Acquired angioedema [J].
Marco Cicardi ;
Andrea Zanichelli .
Allergy, Asthma & Clinical Immunology, 6 (1)
[2]   Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation [J].
Cugno, Massimo ;
Castelli, Roberto ;
Cicardi, Marco .
AUTOIMMUNITY REVIEWS, 2008, 8 (02) :156-159
[3]   ANGIOEDEMA WITH ACQUIRED DEFICIENCY OF THE C1BAR INHIBITOR - A CONSTELLATION OF SYNDROMES [J].
FRIGAS, E .
MAYO CLINIC PROCEEDINGS, 1989, 64 (10) :1269-1275
[4]   Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma [J].
Hengge, UR ;
Ruzicka, T ;
Tyring, SK ;
Stuschke, M ;
Roggendorf, M ;
Schwartz, RA ;
Seeber, S .
LANCET INFECTIOUS DISEASES, 2002, 2 (06) :344-352
[5]   Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman's disease [J].
Lee, Siow Ming ;
Edwards, Simon G. ;
Chilton, Daniella N. ;
Ramsay, Alan ;
Miller, Robert F. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11) :1979-1981
[6]   Immune reconstitution inflammatory syndrome - Risk factors and treatment implications [J].
Manabe, Yukari C. ;
Campbell, James D. ;
Sydnor, Emily ;
Moore, Richard D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (04) :456-462
[7]  
Müller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8
[8]  
Mylona EE, 2008, AIDS REV, V10, P25
[9]   Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients [J].
Oksenhendler, E ;
Duarte, M ;
Soulier, J ;
Cacoub, P ;
Welker, Y ;
Cadranel, J ;
CazalsHatem, D ;
Autran, B ;
Clauvel, JP ;
Raphael, M .
AIDS, 1996, 10 (01) :61-67
[10]   Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma? [J].
Sayer, R. ;
Paul, J. ;
Tuke, P. W. ;
Hargreaves, S. ;
Noursadeghi, M. ;
Tedder, R. S. ;
Grant, P. ;
Edwards, S. G. ;
Miller, R. F. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (10) :585-589